NIAID staff names are bolded in the references below, with links to PubMed records (where available).
To receive copies of any of these documents, please send an email to firstname.lastname@example.org. The email should include the name of the document, as shown below.
Coleman, C. Norman; Hafer, Nathaniel; Maidment, Bert; Manning, Ronald; Prasanna, Pat; and Okunieff, Paul; Chapter: “Radiological and Nuclear Terrorism: Relevance to the Radiation Oncology and Biology Communities,” pgs 293-311 in ALERT – Adverse Late Effects of Cancer Treatment, Medical Radiology, Medical Oncology, editors, Rubi P et. al., publisher: Springer-Verlag, Berlin Heidelberg (2014)
Coleman NC, Adams S, Adrianopoli C, Ansari A, Bader JL, Buddemeier B, Caro J, Casagrande R, Case C, Caspary K, Chan AS, Chang HF, Chao N, Cliffer KD, Confer D, Deitchman S, DeRenzo EG, Dobbs A, Dodgen D, Donnelly EH, Gorman S, Grace MB, Hatchett R, Hick JL, Hrdina C, Jones R, Kane E, Knebel A, Koerner JF, Laffan AM, Larson L, Livinski A, MacKinney J, Maidment BW, Manning R, Marinissen MJ, Martin C, Michael G, Murrain-Hill P, Nemhauser JB, Norwood AE, Nystrom S, Raheem M, Redlener I, Sheehan K, Simon SL, Taylor TP, Toner E, Wallace KS, Wieder J, Weinstock DM, Wiley AL, and Yeskey K, “Medical Planning and Response for a Nuclear Detonation: A Practical Guide,” BioSecurity and Bioterrorism: Biodefense Strategy, Practice, and Science 10(4):346-371 (2012)
Rios CI, Cassatt DR, DiCarlo AL, Macchiarini F, Ramakrishnan N, Norman M-K, Maidment BW. Building the Strategic National Stockpile through the NIAID Radiation Nuclear Countermeasures Program. (PDF) Drug Dev Res. 2-14;75:23-28.
DiCarlo AL, Jackson IL, Shah JR, Czarniecki CW, Maidment BW, Williams JP. Development and Licensure of Medical Countermeasures to Treat Lung Damage Resulting from a Radiological or Nuclear Incident. Radiat Res. 2012 Apr;177:717-721.
Williams JP, Jackson IL, Shah JR, Czarniecki CW, Maidment BW, DiCarlo AL. Animal Models and Medical Countermeasures Development for Radiation-Induced Lung Damage: Report from an NIAID Workshop. Radiat Res. 2012 Apr;177:e0025-e0039.
DiCarlo AL, Poncz M, Cassatt DR, Shah JR, Czarniecki CW, Maidment BW. Medical countermeasures for platelet regeneration after radiation exposure. Report of a workshop and guided discussion sponsored by the National Institute of Allergy and Infectious Diseases, Bethesda, MD, March 22–23, 2010. Radiat Res. 2011 Jul;176(1):e0001-15.
DiCarlo AL, Poncz M, Cassatt DR, Shah JR, Czarniecki CW, Maidment BW. Development and licensure of medical countermeasures for platelet regeneration after radiation exposure. Radiat Res. 2011 Jul;176(1):134-7.
DiCarlo AL, Maher C, Hick JL, Hanfling D, Dainiak N, Chao N, Bader JL, Coleman CN, Weinstock DM. Radiation injury after a nuclear detonation: medical consequences and the need for scarce resources allocation. Disaster Med Public Health Prep. 2011 Mar;5 Suppl 1:S32-44.
DiCarlo AL, Ramakrishnan N, Hatchett RJ. Radiation combined injury: overview of NIAID research. Health Phys. 2010 Jun;98(6):863-7.
Ross JR, Case C, Confer D, Weisdorf DJ, Weinstock D, Krawisz R, Chute J, Wilhauk J, Navarro W, Hartzman R, Norman Coleman C, Hatchett R, Chao N. Radiation Injury Treatment Network (RITN): Healthcare professionals preparing for a mass casualty radiological or nuclear incident. Int J Radiat Biol. 2011 Aug;87(8):748-53.
Grace MB, Moyer BR, Cliffer KD, Kaminski J, Coleman CN, Manning RG, Maidment BW, and Hatchett R. Rapid radiation dose assessment for radiological public health emergencies: Roles of NIAID and BARDA. Health Phys. 2010; 98(2):172-178 (2010)
Hafer N, Maidment B, Hatchett R. The NIAID radiation/nuclear medical countermeasures business model. Biosecur Bioterr. 2010; 8(4): 357-363 (2010)
Hafer N, Cassatt DR, DiCarlo A, Ramakrishnan N, Kaminski J, Norman M-K, Maidment B, and Hatchett R. NIAID/NIH Radiation/Nuclear Medical Countermeasures Product Research and Development Program. Health Phys. 2010;98(6): 903-905.
DiCarlo AL, Fuldner R, Kaminski J, Hodes R. Aging in the context of immunological architecture, function and disease outcomes. Trends Immunol. 2009 Jul;30(7):293-4.
Ramakrishnan N, Norman M, DiCarlo A, Kaminski J, Maidment B, Cassatt D, Benjamin J, Hatchett R. Research and development of medical countermeasures for radiation injury. Indian Journal of Radiat Res. 2009; 6:2-5.
Maidment B, Benjamin J, Cassatt D, DiCarlo A, Kaminski J, Ramakrishnan N, Hatchett R. Radiation/nuclear medical countermeasures development program. 12th International Congress of the International Radiation Protection Association. 2008;263.
Cassatt DR, Kaminski JM, Hatchett RJ, DiCarlo AL, Benjamin JM, Maidment BW. Medical countermeasures against nuclear threats: radionuclide decorporation agents. Radiat Res. 2008;177(4): 540–548.
Ramakrishnan N, Brenner D. Meeting Report: Predicting Individual Radiation Sensitivity: Current and Evolving Technologies. Radiat Res. 2008;170:660-675.
DiCarlo AL, Hatchett RJ, Kaminski JM, Ledney GD, Pellmar TC, Okunieff P, Ramakrishnan N. Medical countermeasures for radiation combined injury: radiation with burn, blast, trauma and/or sepsis. report of an NIAID Workshop, March 26-27, 2007. Radiat Res. 2008 Jun;169(6):712-21.
Weinstock DM, Case C Jr, Bader JL, Chao NJ, Coleman CN, Hatchett RJ, Weisdorf DJ, Confer DL. Radiologic and nuclear events: contingency planning for hematologists/oncologists. Blood. 2008 Jun 15;111(12):5440-5.
Augustine AD, Gondre-Lewis T, McBride W, Miller L, Pellmar TC, Rockwell S. Meeting Report: Animal models for radiation injury, protection and therapy. Radiat Res. 2005;164:100–109.
Last Updated December 23, 2014